7,8-(methylenedioxy)-14-hydroxyberbane has been researched along with fluoxetine in 1 studies
Studies (7,8-(methylenedioxy)-14-hydroxyberbane) | Trials (7,8-(methylenedioxy)-14-hydroxyberbane) | Recent Studies (post-2010) (7,8-(methylenedioxy)-14-hydroxyberbane) | Studies (fluoxetine) | Trials (fluoxetine) | Recent Studies (post-2010) (fluoxetine) |
---|---|---|---|---|---|
40 | 0 | 0 | 10,100 | 1,663 | 3,263 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caron, MG; Kiss, JP; Vizi, ES; Zsilla, G | 1 |
1 other study(ies) available for 7,8-(methylenedioxy)-14-hydroxyberbane and fluoxetine
Article | Year |
---|---|
Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Berberine; Electric Stimulation; Female; Fluoxetine; Frontal Lobe; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Receptors, Adrenergic, alpha-2; Serotonin Plasma Membrane Transport Proteins; Symporters | 2004 |